#United States #Miami #dermatology #Galderma

Galderma Expands Its Operations in Miami

In a strategic move to strengthen its position in the rapidly growing dermatology market, Galderma has officially opened its new headquarters in Miami, Florida. This new facility marks a significant step in the company’s commitment to the U.S. and Latin America, where demand for dermatological skincare and injectable aesthetics continues to soar.

Located in the vibrant Brickell district, the new headquarters will serve as the operational hub for Galderma’s extensive U.S. business. Given that the United States represents Galderma's largest market, this investment underscores the company's confidence in the region's potential. The opening of this facility aligns with Galderma's announced strategy to invest over $650 million in U.S. manufacturing by 2030, further cementing its dedication to growth in this key market.

The new space emphasizes collaboration among Galderma's leadership teams. By bringing together key personnel responsible for various aspects of the business, the company aims to enhance decision-making processes and foster a culture of teamwork. Expecting to employ around 200 staff members over time, the headquarters illustrates Galderma’s long-term investment outlook in Miami and the wider region.

A Focus on Education and Training

The headquarters is designed not only as an operational base but also as a center for education, reflecting Galderma's commitment to professional development. It features a specialized injection room for hands-on training programs and the creation of educational resources, designed to better equip healthcare professionals in the dermatology field. The facility also showcases an installation based on the ALASTIN Signature Practice experience, offering professionals a practical overview of how peri-procedural skincare is integrated into everyday patient care.

In 2026 alone, Galderma has hosted over 1,000 training events under its Galderma Aesthetic Injector Network (GAIN) initiative, training nearly 5,000 individuals. These efforts demonstrate the company’s dedication to enhancing the skills of healthcare providers and improving patient outcomes.

Why Miami?

Miami was selected as the location for Galderma’s new headquarters for multiple reasons. Its reputation as a premium market for dermatological products, along with its wealth of scientific and commercial talent, positions it as an ideal location for fostering innovation in the field. The city's robust connectivity to both the U.S. and Latin America also supports Galderma’s business operations and facilitates stronger relationships with healthcare professionals, partners, and customers.

CEO Flemming Ørnskov highlighted the strategic importance of the investment: "The United States is central to Galderma's long-term growth. By consolidating our leadership teams here, we create a strategic hub that strengthens collaboration and enhances our Integrated Dermatology Strategy's efficacy."

Commitment to Growth

Galderma's new headquarters is just one part of a larger growth strategy aimed at expanding its presence in the U.S. market. The company has recently reported impressive financial performance, with net sales reaching $3.134 billion in the first half of 2026 – a 24.6% increase year-on-year at constant currency. This remarkable growth is attributed to the demand for its leading products in the Injectable Aesthetics and Dermatological Skincare categories.

With a diverse and science-driven portfolio that includes well-known brands such as Dysport®, Restylane®, and Cetaphil®, Galderma aims to leverage its new headquarters to further enhance collaboration among its teams and streamline operations, which is pivotal for its ongoing expansion efforts.

A Modern Workplace

The design of the Miami headquarters reflects Galderma’s dedication to innovation, employee wellbeing, and teamwork. Drawing inspiration from the Japandi design principles, which blend Scandinavian minimalism with Japanese functionality, the interior of the building creates an inviting and modern environment. This design not only fosters creativity and collaboration among team members but also illustrates Galderma's commitment to scientific excellence.

In summary, Galderma’s new U.S. and Latin America headquarters in Miami stands as a testament to the company's strategic ambitions, ongoing investment in dermatology, and dedication to meeting the evolving needs of both consumers and healthcare professionals.